Follow-up for death or recurrence is not a reliable way of assessing the accuracy of diagnostic tests for thromboembolic disease

Chest

Volumn 111, Issue 5, 1997, Pages 1410-1413

  Egermayer, Paul ^a,b  

^a Canterbury Resp Research Group   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

deep vein thrombosis; diagnosis; mortality; natural history; pulmonary embolism; recurrence

Indexed keywords

ANTICOAGULATION; ARTICLE; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 0030973274     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.5.1410     Document Type: Article

References (29)

1. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest 1995; 107:10S-7S
2. Havig O. Deep vein thrombosis and pulmonary embolism: an antopsy study with multiple regression analysis of possible risk factors. Acta Chir Scand 1977; 478(suppl):1-108
3. De Takats G, Jesser JH. Pulmonary embolism: suggestions for its diagnosis, prevention and management. JAMA 1940; 114:1415-21
4. Baner G. Early diagnosis of venous thrombosis by means of venography and abortive treatment with heparin. Acta Med Scand 1941; 107:136-47
5. Egermayer P. Value of anticoagulants in the treatment of pulmonary embolism: a discussion paper. J R Soc Med 1981; 74:675-81
6. Schauble JF, Anlyan WG, Deaton HL, et al. A study of recurrent pulmonary embolism. Arch Surg 1960; 80:113-18
7. Browse NL, Thomas ML, Solan MJ, et al. Prevention of recurrent pulmonary embolism. BMJ 1969; 3:382-86
8. Barritt DW, Jordan SC. Anticoagulant drugs in treatment of pulmonary embolism: a controlled trial. Lancet 1960; 1:309-12
9. Johnson R, Charnley J. Treatment of pulmonary embolism in total hip replacement. Clin Orthop 1977; 124:149-54
10. Nielsen HK, Husted SE, Krusell LR, et al. Silent pulmonary embolism in patients with deep venous thrombosis: incidence and fate in a randomised, controlled trial of anticoagulation versus no anticoagulation. J Intern Med 1994; 235:457-61
11. Barritt DW, Jordan SC. Clinical features of pulmonary embolism. Lancet 1961; 1:729-33
12. Coon WW, Willis PW, Symons MJ. Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg 1969; 170:559-68
13. Kruit WHJ, De Boer AC, Sing AK, et al. The significance of venography in the management of patients with clinically suspected pulmonary embolism. J Intern Med 1991; 230: 333-39
14. Hull RD, Raskob GE, Ginsberg JS, et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 1994; 154:289-97
15. Perrier A, Bounameaux H, Morabia A, et al. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography, a management study. Arch Intern Med 1996; 156: 531-36
16. Nielsen HK, Husted SE, Krusell LR, et al. Anticoagulant therapy in deep venons thrombosis: a randomised controlled study. Thromb Res 1994; 73:215-26
17. Stein PD, Henry JW, Relyea B. Untreated patients with pulmonary embolism: outcome, clinical, and laboratory assessment. Chest 1995; 107:931-35
18. Coon WW, Willis PW. Recurrence of venous thromboembolism. Surgery 1973; 73:823-27
19. Monreal M, Ruiz J, Salvador R, et al. Recurrent pulmonary embolism: a prospective study. Chest 1989; 95:976-79
20. Donnamaria V, Palla A, Petruzzeli S, et al. Early and late follow up of pulmonary embolism. Respiration 1993; 60:15-20
21. Monreal M, Lafoz E, Ruiz J, et al. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study. Eur J Vasc Surg 1994; 8:584-89
22. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7
23. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of 6 weeks with 6 months of oral anticoagulant therapy after a first episode of venous thromboembolism: duration of anticoagulation trial study group. N Engl J Med 1995; 332:1661-65
24. Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979; 301:855-58
25. Wessler S, Gitel S. Rethrombosis - warfarin or low dose heparin? N Engl J Med 1979; 301:889-91
26. Henry JW, Relyea B, Stein PD. Continuing risk of thromboemboli among patients with normal pulmonary angiograms. Chest 1995; 107:1375-78
27. Monreal M, Ruiz J, Olazabal A, et al. Deep venous thrombosis and the risk of pulmonary embolism: a systematic study. Chest 1992; 102:677-81
28. Levine MN, Hirsh J, Gent M, et al. Optimal duration of oral anticoagulant therapy: a randomised trial comparing 4 weeks with 3 months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74:606-11
29. British Thoracic Society Research Committee. Optimum duration of anticoagulation for deep venous thrombosis and pulmonary embolism. Lancet 1992; 340:873-76